Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: A Scandinavian single-center experience

References

• European Liver Transplant Registry; Results; specific results by disease [database on the Internet]. 2010. Available from http://www.eltr.org.
   Google Scholar
• Annual Report 2009; Chapter IV; Liver transplantation in the United States 1999–2008 [database on the Internet]. 2009. Available from http://optn.transplant.hrsa.org.
   Google Scholar
• Norda R, Duberg AS, Sonnerborg A, Olcen P. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990–1992. Scand J Infect Dis 1995;27:449–52.
   PubMed Web of Science ®Google Scholar
• Hoffmann G, Berglund G, Elmstahl S, Eriksson S, Verbaan H, Widell A, Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population. Scand J Gastroenterol 2000;35:861–5.
   PubMed Web of Science ®Google Scholar
• The Nordic Liver transplant Registry (NLTR) Annual report 2010 [database on the Internet]. 2011. Available from http://www.scandiatransplant.org.
   Google Scholar
• Melum E, Friman S, Bjoro K, Rasmussen A, Isoniemi H, Gjertsen H, Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma. J Hepatol 2007;47:777–83.
   PubMed Web of Science ®Google Scholar
• Selzner M, Kashfi A, Selzner N, McCluskey S, Greig PD, Cattral MS, Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation. Liver Transpl 2009;15:1288–95.
   PubMed Web of Science ®Google Scholar
• Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Camma C, Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl 2007;13:733–40.
   PubMed Web of Science ®Google Scholar
• Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation 2004;77:84–92.
   PubMed Web of Science ®Google Scholar
• Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999;29:250–6.
   PubMed Web of Science ®Google Scholar
• Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 2004;41:830–6.
   PubMed Web of Science ®Google Scholar
• Berenguer M, Aguilera V, Prieto M, San Juan F, Rayon JM, Benlloch S, Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression. J Hepatol 2006;44:717–22.
   PubMed Web of Science ®Google Scholar
• Briceno J, Ciria R, Pleguezuelo M, de la Mata M, Muntane J, Naranjo A, Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl 2009;15:37–48.
   PubMed Web of Science ®Google Scholar
• Bahra M, Jacob D, Neumann UP, Spies F, Langrehr JM, Berg T, Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C. Transplantation 2007;84:144–8.
   PubMed Web of Science ®Google Scholar
• Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–9.
   PubMed Web of Science ®Google Scholar
• Westin J, Nordlinder H, Lagging M, Norkrans G, Wejstal R. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol 2002;37:837–42.
   PubMed Web of Science ®Google Scholar
• Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Liver Transpl 2004;10:1240–7.
   PubMed Web of Science ®Google Scholar
• Lo IJ, Lefkowitch JH, Feirt N, Alkofer B, Kin C, Samstein B, Utility of liver allograft biopsy obtained at procurement. Liver Transpl 2008;14:639–46.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Vasuri F, Ravaioli M, Ridolfi L, Grigioni WF, Pinna AD, Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. Liver Transpl 2009;15:1821–5.
   PubMed Web of Science ®Google Scholar
• Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Liver Int 2007;27:758–63.
   PubMed Web of Science ®Google Scholar
• Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl 2009;15:619–28.
   PubMed Web of Science ®Google Scholar
• Verran D, Kusyk T, Painter D, Fisher J, Koorey D, Strasser S, Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003;9:500–5.
   PubMed Web of Science ®Google Scholar
• de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, Grade of Deceased Donor Liver Macrovesicular Steatosis Impacts Graft and Recipient Outcomes More than Donor Risk Index. J Gastroenterol Hepatol 2011;27:540–6.
   Web of Science ®Google Scholar
• O'Leary JG, Randall H, Onaca N, Jennings L, Klintmalm GB, Davis GL. Post-liver transplant survival in hepatitis C patients is improving over time. Liver Transpl 2009;15:360–8.
   PubMed Web of Science ®Google Scholar
• Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation 2004;77:226–31.
   PubMed Web of Science ®Google Scholar
• Samonakis DN, Triantos CK, Thalheimer U, Quaglia A, Leandro G, Teixeira R, Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. Liver Transpl 2005;11:386–95.
   PubMed Web of Science ®Google Scholar
• Briceno J, Ciria R, Pleguezuelo M, Naranjo A, Sanchez-Hidalgo J, Ruiz-Rabelo J, Contribution of marginal donors to liver transplantation for hepatitis C virus infection. Transplant Proc 2007;39:2297–9.
   PubMed Web of Science ®Google Scholar
• Russo MW, Galanko JA, Zacks SL, Beavers KL, Fried MW, Shrestha R. Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C. Am J Transplant 2004;4:1133–8.
   PubMedGoogle Scholar
• Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 2007;84:331–9.
   PubMed Web of Science ®Google Scholar
• Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transpl 2007;13:975–83.
   PubMed Web of Science ®Google Scholar
• Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl 2009;15:1872–81.
   PubMed Web of Science ®Google Scholar
• Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl 2006;12:1496–503.
   PubMed Web of Science ®Google Scholar